Evidence map›Paper›PMID 29257249›Full record

ArticleMolecular medicine reports2018

Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF‑κB signaling pathway.

Han Zhang, Nan Yang, Tianyue Wang, Bing Dai, Yunxiao Shang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Vitamin DScientific reports · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Vitamin DFrontiers in pharmacology · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Vitamin D supplementation as a rational pharmacological approach in the COVID-19 pandemic.American journal of physiology. Lung cellular and molecular physiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Han ZhangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Nan YangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Tianyue WangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Bing DaiDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
Yunxiao ShangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate the effects of vitamin D (VD) on inflammatory responses in asthmatic mice and the underlying mechanism, providing a theoretical basis for clinical application of targeted drug therapy, and the development of novel drugs against asthma. Mouse models of asthma were established. Hematoxylin‑eosin staining was performed to observe the pathological changes of the lung tissue. Pulmonary function tests were conducted to determine airway resistance in asthmatic mice. ELISA was performed to measure the serum levels of inflammatory factors. Western blot analysis and reverse transcription‑quantitative polymerase chain reaction were performed to determine the changes in apoptosis‑inducing factors, and high mobility group box 1 protein (HMGB1)/Toll‑like receptor‑4 (TLR4)/nuclear factor (NF)‑κB signaling pathway‑related proteins. VD reduced infiltrated inflammatory factors, attenuated the airway resistance of asthmatic mice, decreased serum levels of interleukin (IL)‑1β, IL‑6, tumor necrosis factor (TNF)‑α, increased serum levels of IL‑10, decreased apoptotic factor Bcl‑2‑associated X and caspase‑3 expression, downregulated HMGB1 and TLR4, NF‑κB and phosphorylated‑NF‑κB p65 expression. When TLR4 expression was inhibited, the anti‑inflammatory effects of VD were attenuated, and HMGB1, TLR4, NF‑κB and p‑NF‑κB p65 expression was increased. VD was able reduce the inflammatory response of asthmatic mice and apoptosis in lung tissue through the HMGB1/TLR4/NF‑κB signaling pathway.

Indexed as

AnimalsAnti-Inflammatory AgentsAsthmaHMGB1 ProteinLungMiceMice, Inbred BALB CNF-kappa BSignal TransductionToll-Like Receptor 4Vitamin DVitaminsAnti-Inflammatory AgentsHMGB1 ProteinNF-kappa BTlr4 protein, mouseToll-Like Receptor 4Vitamin DVitamins

Identifiers

PMID29257249
PMCPMC5783507
OpenAlexW2772492756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.